News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb ...
A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.
GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...
Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.
Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...
ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, ...
Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...
will be presented at the European Hematology Association (EHA) 2025 Hybrid Congress, taking place June 12-15, 2025, in Milan, Italy and online. The presentation will highlight initial results from ...
4d
Clinical Trials Arena on MSNNovartis reports positive results from Phase IIIB study of iptacopan for PNHDuring the trial, none of the participants needed blood transfusions, and 92.7% of them reached Hb levels of at least 12g/dL.
Following the 18th European Hematology Association Congress, pharmaphorum's Hannah Blake spoke with hematology expert, Dr Moshe Talpaz, to find out more about the research and development ...
today announced its abstract has been selected for a poster presentation at the 2025 European Hematology Association Annual Meeting (EHA) being held June 12-15 in Milan, Italy. The abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results